ArticleCureus2025
Paraneoplastic Pemphigus in a Patient With Relapsed Breast Cancer: An Uncommon Presentation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paraneoplastic pemphigus (PNP) is a rare and severe autoimmune mucocutaneous blistering disorder most commonly associated with hematologic malignancies. Its occurrence in solid tumors, particularly breast cancer, is exceedingly uncommon. PNP may precede, coincide with, or signal recurrence of an underlying neoplasm. We report the case of a 65-year-old woman presenting with a six-month history of recurrent, painless palatal blisters. Clinical examination revealed multiple intraoral vesicles and a subtly positive Nikolsky sign. Her medical history was notable for breast cancer treated 11 years prior, with oncology discharge in 2021. Biopsy with histopathology and direct immunofluorescence confirmed intraepithelial blistering with IgG deposition, consistent with PNP. Positron Emission Tomography - Computed Tomography (PET-CT) demonstrated widespread recurrence of breast cancer with nodal, hepatic, adrenal, and osseous involvement. The oral lesions were managed successfully with low-dose topical corticosteroids, while systemic treatment for metastatic breast cancer included chemotherapy and palliative radiotherapy. This case highlights an unusual presentation of PNP secondary to recurrent breast cancer more than a decade after initial treatment. The subtle but persistent mucosal lesions served as an early clinical clue to underlying malignancy progression. Prompt recognition and biopsy-based confirmation were essential to establishing the diagnosis and guiding oncologic management. PNP should be considered in the differential diagnosis of chronic, unexplained oral vesiculobullous lesions, even in patients with remote histories of solid tumors. Heightened clinical suspicion may facilitate earlier detection of malignancy recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.